Related Experiment Video
Updated: May 13, 2025

14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.6K
Neural network localization in Parkinson's disease with impulse control disorders
Hucheng Yang1,2, Siyu Gu1, Haihua Sun3
1Department of Radiology, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, China.
Frontiers in Aging Neuroscience
|April 14, 2025
Summary
Neuroimaging in Parkinson's disease (PD) with impulse control disorders (ICDs) shows varied results. This study identifies a common network, involving the default mode and subcortical networks, underlying these differences.
Area of Science:
- Neuroimaging
- Neurology
- Psychiatry
Background:
- Parkinson's disease (PD) exhibits significant heterogeneity in magnetic resonance imaging (MRI) findings concerning impulse control disorders (ICDs).
- Previous studies on PD with ICDs have identified diverse brain regions, leading to a lack of consensus.
- A unifying network hypothesis was proposed to reconcile these disparate findings.
Purpose of the Study:
- To systematically review existing MRI studies on PD with ICDs.
- To identify a common neural network affected in PD with ICDs using a novel functional connectivity network mapping (FCNM) technique.
- To integrate and explain the heterogeneity observed in neuroimaging findings for PD with ICDs.
Main Methods:
- Conducted a systematic literature review of structural and functional MRI studies in PD with ICDs.
- Utilized the Human Connectome Project (HCP) dataset (n=1,093) for network analysis.
- Applied a novel FCNM technique to identify shared aberrant neural networks.
Main Results:
- Analyzed 19 studies involving 345 individuals with PD and ICDs and 787 with PD without ICDs.
- Identified aberrant neural networks primarily involving the default mode network (DMN) and subcortical network.
- Specific DMN regions include the middle/inferior temporal gyrus, anterior cingulate cortex, and angular gyrus; the caudate nucleus was identified in the subcortical network.
Conclusions:
- Heterogeneous neuroimaging findings in PD with ICDs are explained by shared abnormalities in the DMN and subcortical network.
- These network dysfunctions are linked to impaired self-regulation, decision-making, and increased impulsivity in PD.
- The study provides a network-level understanding of the neurobiological mechanisms underlying PD with ICDs, integrating diverse previous findings.
Keywords:
Parkinson’s diseasefunctional connectivity network mappingimpulse control disordersnetwork localizationvoxel-based morphometryMore Related Videos
Related Concept Videos
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Parkinson's Disease: Treatment
154
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
154
Parkinson's Disease: Overview
323
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
323

